Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Shares Sold by Federated Hermes Inc.

Federated Hermes Inc. lowered its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 70.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,524 shares of the company’s stock after selling 99,160 shares during the quarter. Federated Hermes Inc. owned 0.07% of Bioceres Crop Solutions worth $584,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Raymond James & Associates boosted its stake in shares of Bioceres Crop Solutions by 4.9% during the 3rd quarter. Raymond James & Associates now owns 27,567 shares of the company’s stock valued at $311,000 after buying an additional 1,300 shares during the last quarter. Ballast Asset Management LP acquired a new position in Bioceres Crop Solutions during the 3rd quarter worth $2,210,000. Polar Capital Holdings Plc bought a new stake in shares of Bioceres Crop Solutions in the 3rd quarter worth about $2,112,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of Bioceres Crop Solutions by 46.7% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 136,635 shares of the company’s stock worth $1,876,000 after purchasing an additional 43,484 shares during the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Stock Performance

BIOX stock opened at $12.14 on Friday. The firm has a market cap of $762.36 million, a P/E ratio of 37.94 and a beta of 0.63. The stock’s 50 day simple moving average is $12.63 and its 200 day simple moving average is $12.56. The company has a current ratio of 1.24, a quick ratio of 0.84 and a debt-to-equity ratio of 0.33. Bioceres Crop Solutions Corp. has a 12-month low of $9.76 and a 12-month high of $14.20.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Thursday, February 8th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. Bioceres Crop Solutions had a net margin of 4.36% and a return on equity of 5.96%. The company had revenue of $140.30 million for the quarter, compared to analysts’ expectations of $108.97 million. During the same period in the prior year, the company earned ($0.14) earnings per share. As a group, equities research analysts predict that Bioceres Crop Solutions Corp. will post 0.45 EPS for the current year.

Analysts Set New Price Targets

Separately, Roth Mkm lifted their price target on Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a “buy” rating in a research note on Friday, February 9th.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.